Ainos, Inc. financial data

Symbol
AIMD, AIMDW on Nasdaq
Industry
Pharmaceutical Preparations
Location
Ainos, Inc., 8880 Rio San Diego Drive Suite 800, San Diego, CA
State of incorporation
TX
Fiscal year end
December 31
Former names
AMARILLO BIOSCIENCES INC (to 3/30/2021)
Latest financial report
10-Q - Q2 2024 - Aug 5, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 123 % -19%
Quick Ratio 5.72 %
Debt-to-equity 37.1 % +278%
Return On Assets -47.1 % -16.6%
Operating Margin -14.7K %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 7.66M shares -62.2%
Common Stock, Shares, Outstanding 7.39M shares -63.1%
Entity Public Float 5.22M USD
Common Stock, Value, Issued 73.9K USD -63.6%
Weighted Average Number of Shares Outstanding, Basic 6.52M shares +62.2%
Weighted Average Number of Shares Outstanding, Diluted 6.52M shares +62.2%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 93.7K USD -57.8%
Cost of Revenue 271K USD -54.5%
Research and Development Expense 8.01M USD +14.4%
Operating Income (Loss) -14.5M USD +1.57%
Nonoperating Income (Expense) -864K USD -341%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -15.4M USD -36%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -15.4M USD -3.96%
Earnings Per Share, Basic -0.49 USD/shares +15.5%
Earnings Per Share, Diluted -0.49 USD/shares +15.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 8.01M USD +489%
Accounts Receivable, after Allowance for Credit Loss, Current 9 USD -99.9%
Inventory, Net 166K USD -68.5%
Other Assets, Current 291K USD
Assets, Current 8.47M USD +296%
Property, Plant and Equipment, Net 691K USD -45.6%
Intangible Assets, Net (Excluding Goodwill) 26M USD
Other Assets, Noncurrent 349K USD +376%
Assets 35.5M USD +4.39%
Accounts Payable, Current 109K USD
Liabilities, Current 5.74M USD +416%
Operating Lease, Liability, Noncurrent 3.28K USD
Other Liabilities, Noncurrent 83.9K USD +123%
Liabilities 14.8M USD +306%
Accumulated Other Comprehensive Income (Loss), Net of Tax -380K USD
Retained Earnings (Accumulated Deficit) -44.4M USD -53.2%
Stockholders' Equity Attributable to Parent 20.7M USD -31.9%
Liabilities and Equity 35.5M USD +4.39%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.49M USD -4.37%
Net Cash Provided by (Used in) Financing Activities 778K USD -2.81%
Net Cash Provided by (Used in) Investing Activities -111K USD -53.5%
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Shares, Issued 7.39M shares -63.6%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -855K USD -20.9%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 8.01M USD +489%
Deferred Tax Assets, Valuation Allowance 9.02M USD +21.1%
Payments to Acquire Property, Plant, and Equipment 4.43K USD -93.9%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -15.5M USD -4.68%
Property, Plant and Equipment, Gross 1.81M USD +7.31%
Operating Lease, Liability, Current 24.2K USD
Deferred Tax Assets, Operating Loss Carryforwards 7.39M USD +14.1%
Preferred Stock, Shares Issued 0 shares -100%
Preferred Stock, Shares Authorized 50M shares
Additional Paid in Capital 65.4M USD +10.1%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 9.02M USD +20.8%
Share-based Payment Arrangement, Expense 422K USD +208%
Interest Expense 48.7K USD +425%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%